XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

The following table describes for the quarterly period ended December 31, 2025, each trading arrangement for the sale or purchase of Company securities adopted or terminated by our directors and officers that is either (1) a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a Rule 10b5-1 trading arrangement) or (2) a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K):

Name (Title)

Action Taken
(Date of Action)

Type of Trading Arrangement

Nature of Trading
Arrangement

Duration of Trading
Arrangement

Aggregate Number
of Securities

Alexandra Balcom
(Chief Financial Officer)

Adoption
(December 23, 2025)

Rule 10b5-1 trading arrangement

Sale

Until December 11, 2026, or such earlier date upon which all transactions are completed or expire without execution

Up to 128,000 shares of Class A common stock

Henry Pelish
(Chief Scientific Officer)

Adoption
(December 11, 2025)

Rule 10b5-1 trading arrangement

Sale

Until November 30, 2027, or such earlier date upon which all transactions are completed or expire without execution

Up to 116,306 shares of Class A common stock

James Porter
(Chief Executive Officer)

Adoption
(December 4, 2025)

Rule 10b5-1 trading arrangement

Sale

Until March 10, 2027, or such earlier date upon which all transactions are completed or expire without execution

Up to 390,000 shares of Class A common stock

Anna Protopapas
(Director)

Adoption
(December 7, 2025)

Rule 10b5-1 trading arrangement

Sale

Until March 31, 2027, or such earlier date upon which all transactions are completed or expire without execution

Up to 20,000 shares of Class A common stock

 

Rule 10B 5-1Trading Plan [Member] | Alexandra Balcom [Member]  
Trading Arrangements, by Individual  
Name Alexandra Balcom
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 23, 2025
Expiration Date December 11, 2026
Aggregate Available 128,000
Rule 10B 5-1Trading Plan [Member] | Henry Pelish [Member]  
Trading Arrangements, by Individual  
Name Henry Pelish
Title Chief Scientific Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 11, 2025
Expiration Date November 30, 2027
Aggregate Available 116,306
Rule 10B 5-1Trading Plan [Member] | James Porter [Member]  
Trading Arrangements, by Individual  
Name James Porter
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 4, 2025
Expiration Date March 10, 2027
Aggregate Available 390,000
Rule 10B 5-1Trading Plan [Member] | Anna Protopapas [Member]  
Trading Arrangements, by Individual  
Name Anna Protopapas
Title Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 7, 2025
Expiration Date March 31, 2027
Aggregate Available 20,000